Logo image of BARK

BARK INC (BARK) Stock Fundamental Analysis

USA - NYSE:BARK - US68622E1047 - Common Stock

0.8595 USD
-0.01 (-1.51%)
Last: 9/19/2025, 8:04:01 PM
0.859 USD
0 (-0.06%)
After Hours: 9/19/2025, 8:04:01 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BARK. BARK was compared to 121 industry peers in the Specialty Retail industry. While BARK seems to be doing ok healthwise, there are quite some concerns on its profitability. BARK is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

BARK had negative earnings in the past year.
In the past year BARK has reported a negative cash flow from operations.
In the past 5 years BARK always reported negative net income.
In multiple years BARK reported negative operating cash flow during the last 5 years.
BARK Yearly Net Income VS EBIT VS OCF VS FCFBARK Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 -50M -100M -150M

1.2 Ratios

Looking at the Return On Assets, with a value of -11.49%, BARK is doing worse than 77.69% of the companies in the same industry.
BARK's Return On Equity of -31.79% is on the low side compared to the rest of the industry. BARK is outperformed by 64.46% of its industry peers.
Industry RankSector Rank
ROA -11.49%
ROE -31.79%
ROIC N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BARK Yearly ROA, ROE, ROICBARK Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 0 200 400 600 800

1.3 Margins

The Gross Margin of BARK (62.19%) is better than 91.74% of its industry peers.
In the last couple of years the Gross Margin of BARK has remained more or less at the same level.
BARK does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
BARK Yearly Profit, Operating, Gross MarginsBARK Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 20 40 60

5

2. Health

2.1 Basic Checks

BARK does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, BARK has less shares outstanding
The number of shares outstanding for BARK has been reduced compared to 5 years ago.
The debt/assets ratio for BARK is higher compared to a year ago.
BARK Yearly Shares OutstandingBARK Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BARK Yearly Total Debt VS Total AssetsBARK Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M

2.2 Solvency

BARK has an Altman-Z score of 0.17. This is a bad value and indicates that BARK is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of BARK (0.17) is worse than 78.51% of its industry peers.
There is no outstanding debt for BARK. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 0.17
ROIC/WACCN/A
WACC8.58%
BARK Yearly LT Debt VS Equity VS FCFBARK Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 100M -100M 200M

2.3 Liquidity

BARK has a Current Ratio of 1.55. This is a normal value and indicates that BARK is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.55, BARK is in the better half of the industry, outperforming 66.94% of the companies in the same industry.
A Quick Ratio of 0.79 indicates that BARK may have some problems paying its short term obligations.
With a decent Quick ratio value of 0.79, BARK is doing good in the industry, outperforming 68.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 0.79
BARK Yearly Current Assets VS Current LiabilitesBARK Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 75.00% over the past year.
Looking at the last year, BARK shows a decrease in Revenue. The Revenue has decreased by -3.08% in the last year.
The Revenue has been growing by 16.64% on average over the past years. This is quite good.
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
Revenue 1Y (TTM)-3.08%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-11.49%

3.2 Future

BARK is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 55.66% yearly.
BARK is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.20% yearly.
EPS Next Y-287.6%
EPS Next 2Y-42.83%
EPS Next 3Y65.71%
EPS Next 5Y55.66%
Revenue Next Year-16.7%
Revenue Next 2Y-5.92%
Revenue Next 3Y-0.88%
Revenue Next 5Y2.2%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BARK Yearly Revenue VS EstimatesBARK Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 100M 200M 300M 400M 500M
BARK Yearly EPS VS EstimatesBARK Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 0.1 -0.1 -0.2 -0.3 -0.4

1

4. Valuation

4.1 Price/Earnings Ratio

BARK reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year BARK is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BARK Price Earnings VS Forward Price EarningsBARK Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 80

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BARK Per share dataBARK EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

A more expensive valuation may be justified as BARK's earnings are expected to grow with 65.71% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-42.83%
EPS Next 3Y65.71%

0

5. Dividend

5.1 Amount

No dividends for BARK!.
Industry RankSector Rank
Dividend Yield N/A

BARK INC

NYSE:BARK (9/19/2025, 8:04:01 PM)

After market: 0.859 0 (-0.06%)

0.8595

-0.01 (-1.51%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustrySpecialty Retail
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05
Inst Owners44.16%
Inst Owner Change-22.12%
Ins Owners17.28%
Ins Owner Change13.53%
Market Cap146.01M
Analysts82.22
Price Target2.38 (176.91%)
Short Float %9.66%
Short Ratio14
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)39.61%
Min EPS beat(2)-30.72%
Max EPS beat(2)109.93%
EPS beat(4)3
Avg EPS beat(4)746.36%
Min EPS beat(4)-30.72%
Max EPS beat(4)2870.89%
EPS beat(8)7
Avg EPS beat(8)399.78%
EPS beat(12)9
Avg EPS beat(12)266.66%
EPS beat(16)12
Avg EPS beat(16)192.27%
Revenue beat(2)1
Avg Revenue beat(2)-4.77%
Min Revenue beat(2)-10.76%
Max Revenue beat(2)1.21%
Revenue beat(4)2
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-10.76%
Max Revenue beat(4)1.21%
Revenue beat(8)2
Avg Revenue beat(8)-2.07%
Revenue beat(12)4
Avg Revenue beat(12)-1.23%
Revenue beat(16)4
Avg Revenue beat(16)-1.31%
PT rev (1m)0%
PT rev (3m)-22.22%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-50%
EPS NY rev (1m)-52%
EPS NY rev (3m)-396.06%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.18%
Revenue NY rev (1m)-3.14%
Revenue NY rev (3m)-22.7%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B 1.55
P/tB 1.64
EV/EBITDA N/A
EPS(TTM)-0.02
EYN/A
EPS(NY)-0.04
Fwd EYN/A
FCF(TTM)-0.11
FCFYN/A
OCF(TTM)-0.08
OCFYN/A
SpS2.77
BVpS0.55
TBVpS0.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.49%
ROE -31.79%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 62.19%
FCFM N/A
ROA(3y)-13.46%
ROA(5y)-15.38%
ROE(3y)-31.89%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y3.91%
GM growth 5Y0.66%
F-Score5
Asset Turnover1.81
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 44.39%
Cap/Sales 1.02%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.55
Quick Ratio 0.79
Altman-Z 0.17
F-Score5
WACC8.58%
ROIC/WACCN/A
Cap/Depr(3y)117.01%
Cap/Depr(5y)206.52%
Cap/Sales(3y)2.35%
Cap/Sales(5y)2.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)75%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%0%
EPS Next Y-287.6%
EPS Next 2Y-42.83%
EPS Next 3Y65.71%
EPS Next 5Y55.66%
Revenue 1Y (TTM)-3.08%
Revenue growth 3Y-1.55%
Revenue growth 5Y16.64%
Sales Q2Q%-11.49%
Revenue Next Year-16.7%
Revenue Next 2Y-5.92%
Revenue Next 3Y-0.88%
Revenue Next 5Y2.2%
EBIT growth 1Y21.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year102.18%
EBIT Next 3Y36.3%
EBIT Next 5Y25.73%
FCF growth 1Y-134.17%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-225.75%
OCF growth 3YN/A
OCF growth 5YN/A